Why the study?
Does the type of contemporary drug-eluting stent affect the risk of target-vessel failure in patients undergoing complex high-risk indicated procedures?
Does the type of contemporary drug-eluting stent affect the risk of target-vessel failure in patients undergoing complex high-risk indicated procedures?
Answers are grounded in this paper and cite their sources.
In a PCI registry of CHIP patients, different contemporary drug-eluting stents showed differential risks of target-vessel failure, generating hypotheses for future randomized trials.
In this contemporary PCI registry, we observed the differential risks of target-vessel failure according to various types of contemporary DES in patients with CHIP characteristics. However, owing to inherent selection bias, the results should be considered hypothesis-generating, highlighting the need for further randomized trials. (Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice [IRIS-DES]; NCT01186133).
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: